Filing Details

Accession Number:
0001209191-21-063210
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-11-05 17:06:39
Reporting Period:
2021-11-04
Accepted Time:
2021-11-05 17:06:39
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1664710 Keros Therapeutics Inc. KROS Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1808322 Jennifer Lachey C/O Keros Therapeutics, Inc.
99 Hayden Avenue, Suite 120, Building E
Lexington MA 02421
Chief Scientific Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-11-04 10,600 $0.30 96,300 No 4 M Direct
Common Stock Disposition 2021-11-04 10,600 $50.00 85,700 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (right to buy) Disposition 2021-11-04 10,600 $0.00 10,600 $0.30
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
119,105 2028-03-25 No 4 M Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
  2. Immediately exercisable.